Login / Signup

Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA.

Lerato MoetiMadira LiteduJacques Joubert
Published in: Therapeutic innovation & regulatory science (2021)
The most common deficiencies observed by SAHPRA were extensively discussed. These findings could serve as a guidance for API manufacturers to submit better quality APIMFs which will improve turnaround times for registration and accelerate access to medicines for patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • quality improvement